Intuitive Surgical (ISRG) Stock
Key stats
- Market cap
- $165.52B
- Price / Earnings ratio
- 56.5x
- EPS (TTM)
- $8.35
- Volume
- Loading
- 52-week high
- $603.88
- 52-week low
- $328.57
- EPS vs analyst estimate
- +31.9%Q3 FY25 · $2.40 vs $1.82
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with ISRG
Recent news

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
ISRG

Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
ISRG

ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
ISRG

Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
ISRG
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 64.82
- MACD 12/26/9
- 14.14
- EMA 9 of MACD
- 12.61
- MACD histogram
- 1.53
- SMA 50
- $408.22
- Price above SMA 50
- EMA 50
- $419.70
- Price above EMA 50
- SMA 200
- $431.56
- Price above SMA 200
- EMA 200
- $447.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $2.03 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
ISRG

Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
ISRG

ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
ISRG

Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
ISRG

Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
ISRG

Intuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why
Intuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why
ISRG

Earnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy?
Earnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy?
ISRG

2 Beaten-Down Healthcare Stocks to Buy and Hold for the Next Decade
2 Beaten-Down Healthcare Stocks to Buy and Hold for the Next Decade
ISRG

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
ISRG

New Strong Buy Stocks for October 23rd
New Strong Buy Stocks for October 23rd
ISRG
News tone: automated (AI) classification of the article's content, not a price prediction.
About Intuitive Surgical
Intuitive was founded in 1995 to create innovative, robotic-assisted systems that help empower doctors and hospitals to make surgery less invasive than an open approach. Since the da Vinci surgical system became one of the first robotic-assisted systems cleared by the FDA for general laparoscopic surgery, we’ve taken robotic-assisted surgery from “science fiction” to reality. Working with doctors and hospitals, we’re continuing to develop new, minimally invasive surgical platforms and future diagnostic tools to help solve complex healthcare challenges around the world.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. David J. Rosa | CEO & Director | 1968 |
| Dr. Gary S. Guthart Ph.D. | Executive Chair | 1966 |
| Mr. Jamie E. Samath | Executive VP, CFO & Enterprise Technology Leader | 1971 |
| Mr. Henry L. Charlton | Senior VP of Global Business Operations | 1970 |
| Mr. Gary H. Loeb J.D. | Executive VP and Chief Legal & Compliance Officer | 1970 |
| Mr. Mark P. Brosius | Chief Manufacturing and Supply Chain Officer | 1967 |
| Mr. Fredrik Widman | VP, Principal Accounting Officer & Corporate Controller | — |
| Mr. Milind Wagle | Chief Information Officer | — |
| Mr. Daniel P. Connally C.F.A. | VP & Head of Investor Relations | — |
| Dr. Christopher R. Carlson Ph.D. | Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 64.82
- MACD 12/26/9
- 14.14
- EMA 9 of MACD
- 12.61
- MACD histogram
- 1.53
- SMA 50
- $408.22
- Price above SMA 50
- EMA 50
- $419.70
- Price above EMA 50
- SMA 200
- $431.56
- Price above SMA 200
- EMA 200
- $447.63
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
11 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $385.00
- Average
- $480.73
- High
- $550.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -11.2 | +12.3 | ||||||||||
| 2022 | -21.1 | +1.3 | +3.5 | -21.7 | -5.4 | -7.2 | +11.7 | -10.0 | -9.1 | +27.5 | +9.5 | -3.3 |
| 2023 | -7.5 | -8.7 | +12.4 | +18.8 | +1.6 | +10.1 | -3.5 | -3.5 | -5.8 | -11.1 | +14.9 | +7.0 |
| 2024 | +14.3 | +0.5 | +0.3 | -6.1 | +8.2 | +10.1 | +1.9 | +9.2 | +1.6 | +3.9 | +7.0 | -3.8 |
| 2025 | +9.1 | -0.9 | -12.6 | +3.9 | +6.8 | -1.8 | -10.6 | -2.0 | -4.7 | +22.0 | +5.4 | -0.2 |
| 2026 | -10.3 | +1.4 | -7.1 | -1.5 | -7.2 | -3.5 | -12.2 | +0.4 | +10.1 | +7.7 | +7.2 |



